{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:04:38Z","timestamp":1776704678020,"version":"3.51.2"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.medmal.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T08:09:14Z","timestamp":1466237354000},"page":"215-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae"],"prefix":"10.1016","volume":"46","author":[{"given":"A.","family":"Mambie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vuotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Poitrenaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weyrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Cannesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dessein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Faure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Guery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Galp\u00e9rine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2016.04.008_bib0005","unstructured":"Proportion of 3rd gen. cephalosporins Resistant Escherichia coli Isolates in Participating Countries in 2013 \u2013\u00a0European Centre for Disease Prevention and Control."},{"key":"10.1016\/j.medmal.2016.04.008_bib0010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of Carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2016.04.008_bib0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2016.04.008_bib0020","series-title":"Enqu\u00eate BMR AP\u2013HP 2011","author":"Trystram","year":"2012"},{"key":"10.1016\/j.medmal.2016.04.008_bib0025","series-title":"R\u00e9seau BMR \u2013\u00a0r\u00e9sultats 2011","author":"Arnaud","year":"2013"},{"issue":"1","key":"10.1016\/j.medmal.2016.04.008_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-2994-1-25","article-title":"WAAR, international section of the Alliance contre le d\u00e9veloppement des bact\u00e9ries multi-r\u00e9sistantes (AC-de-BMR). WAAR (World Alliance against Antibiotic Resistance): safeguarding antibiotics","volume":"1","author":"Carlet","year":"2012","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.medmal.2016.04.008_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/AAC.6.3.290","article-title":"Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology","volume":"6","author":"Brumfitt","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.04.008_bib0040","series-title":"Diagnostic et antibioth\u00e9rapie des infections urinaires bact\u00e9riennes communautaires de l\u2019adulte \u2013\u00a0Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. Recommandations","year":"2014"},{"issue":"11","key":"10.1016\/j.medmal.2016.04.008_bib0045","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.medmal.2016.04.008_bib0050","series-title":"Comit\u00e9 de l\u2019antibiogramme. Recommandations","author":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie","year":"2013"},{"issue":"11","key":"10.1016\/j.medmal.2016.04.008_bib0055","first-page":"793","article-title":"Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"47","author":"Kern\u00e9is","year":"2015","journal-title":"Infect Dis (Lond)"},{"issue":"8","key":"10.1016\/j.medmal.2016.04.008_bib0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s10096-014-2094-y","article-title":"Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae","volume":"33","author":"Pilmis","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2016.04.008_bib0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.medmal.2012.01.004","article-title":"Cefoxitin and ESBL","volume":"42","author":"Boyer","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2016.04.008_bib0070","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/AAC.06233-11","article-title":"Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum beta-lactamase","volume":"56","author":"Lepeule","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.medmal.2016.04.008_bib0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijantimicag.2014.10.001","article-title":"Evaluation of the efficiency of cefoxitin\/cefepime combination against Enterobacteriaceae resistant to expanded-spectrum cephalosporins","volume":"45","author":"Serres","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2016.04.008_bib0080","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/jac\/dkl381","article-title":"Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates","volume":"58","author":"Lee","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.medmal.2016.04.008_bib0085","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1128\/AAC.02509-14","article-title":"Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"58","author":"Guet-Revillet","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.04.008_bib0090","series-title":"La cefoxitine est-elle efficace en cas de py\u00e9lon\u00e9phrite aigu\u00eb (PNA) \u00e0 Escherichia coli s\u00e9cr\u00e9teur de b\u00eata-lactamase \u00e0 spectre \u00e9tendu\u00a0? R\u00e9union interdisciplinaire de chimioth\u00e9rapie anti-infectieuse","author":"Guet-Revillet","year":"2012"},{"key":"10.1016\/j.medmal.2016.04.008_bib0095","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.15.6.792","article-title":"Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases","volume":"15","author":"Sanders","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.04.008_bib0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/159.5.1005","article-title":"In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiellapneumoniae producing a TEM-3 beta-lactamase","volume":"159","author":"Pangon","year":"1989","journal-title":"J Infect Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16300348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16300348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:14:18Z","timestamp":1759972458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X16300348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0399077X16300348"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2016.04.008","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}